Want to see SE:NNH full AI Analyst Report?
NNH Stock Chart & Stats
kr21.50
kr0.00(0.00%)
At close: 4:00 PM EST
kr21.50
kr0.00(0.00%)
Day’s Range― - ―
52-Week Rangekr11.60 - kr28.00
Previous CloseN/A
Volume5.00K
Average Volume (3M)5.45K
Market Cap
kr74.96M
Enterprise Valuekr111.54M
Total Cash (Recent Filing)kr8.66M
Total Debt (Recent Filing)kr39.66M
Price to Earnings (P/E)28.4
Beta0.32
Next Earnings
Aug 05, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.05%
Share Statistics
EPS (TTM)0.43
Shares Outstanding6,195,200
10 Day Avg. Volume3,153
30 Day Avg. Volume5,451
Financial Highlights & Ratios
PEG Ratio-0.09
Price to Book (P/B)1.39
Price to Sales (P/S)0.25
P/FCF Ratio18.98
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Branded Products & Multi‑channel DistributionA recognizable branded portfolio sold across retail, pharmacy and partner channels in multiple countries supports recurring demand and shelf presence. This distribution breadth and consumer-facing brand help sustain revenue access and competitive positioning over the medium term.
Manageable Leverage And Stable EquityConservative leverage and stable equity provide financial flexibility for marketing, product investment and working capital. Lower debt burden reduces refinancing and interest-rate risk, enabling the company to execute strategy and withstand demand variability without severe balance-sheet strain.
Return To Sustained ProfitabilityRe-establishing positive operating and net results after multi-year losses signals resumed business viability and operational adjustments. Consistent profitability, even if modest, underpins reinvestment, supports modest returns to shareholders and indicates a path toward normalized earnings generation.
Bears Say
Very Thin MarginsExtremely low EBIT and net margins leave minimal buffer against cost inflation, input price shifts or modest volume declines. With little operating leverage, margin compression would quickly erode profits, making earnings and cash generation fragile over the medium term.
Volatile Cash Generation; Sharp FCF DeclineSignificant variability in operating cash flow and a recent sharp free-cash-flow drop undermine confidence in cash conversion. Irregular cash generation constrains capital allocation, increases reliance on external funding for growth or dividends, and raises execution risk across cycles.
Recent Weakness In Revenue GrowthA reversion to negative top-line growth signals pressure on demand, pricing or distribution effectiveness. Slowing or declining revenue makes margin recovery harder and limits scalability of SG&A, increasing the challenge of sustaining profits and returns over the next several quarters.
NNH FAQ
What was New Nordic Healthbrands AB’s price range in the past 12 months?
New Nordic Healthbrands AB lowest stock price was kr11.60 and its highest was kr28.00 in the past 12 months.
What is New Nordic Healthbrands AB’s market cap?
New Nordic Healthbrands AB’s market cap is kr74.96M.
When is New Nordic Healthbrands AB’s upcoming earnings report date?
New Nordic Healthbrands AB’s upcoming earnings report date is Aug 05, 2026 which is in 15 days.
How were New Nordic Healthbrands AB’s earnings last quarter?
New Nordic Healthbrands AB released its earnings results on Apr 29, 2026. The company reported -kr0.462 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.462.
Is New Nordic Healthbrands AB overvalued?
According to Wall Street analysts New Nordic Healthbrands AB’s price is currently Overvalued.
Does New Nordic Healthbrands AB pay dividends?
New Nordic Healthbrands AB pays a Annually dividend of kr0.25 which represents an annual dividend yield of 2.05%. See more information on New Nordic Healthbrands AB dividends here
What is New Nordic Healthbrands AB’s EPS estimate?
New Nordic Healthbrands AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does New Nordic Healthbrands AB have?
New Nordic Healthbrands AB has 6,195,200 shares outstanding.
What happened to New Nordic Healthbrands AB’s price movement after its last earnings report?
New Nordic Healthbrands AB reported an EPS of -kr0.462 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -20.404%.
Which hedge fund is a major shareholder of New Nordic Healthbrands AB?
Currently, no hedge funds are holding shares in SE:NNH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
New Nordic Healthbrands AB
New Nordic Healthbrands AB (publ)., engages in providing dietary supplements, natural medicines and cosmetic products for various health and beauty needs in the Nordic countries, Europe, North America, and internationally. The company provides vitality tablets, capsules, and gummy products, including vitamins and minerals, fish oil and Omega-3, and magnesium, as well as for body, sleep and relaxation, menopause, and men health; skincare products comprising dietary supplements, facial care, and body care, as well as assortment products; hair care products, such as hair volume products, dietary supplements, shampoos, conditioners, serum, and other hair care products; and weight loss products. The company sells its products through pharmacies, health stores,beauty stores, and travel retailers, as well as through online stores. New Nordic Healthbrands AB (publ) was founded in 1990 and is headquartered in Malmö, Sweden.
Technical Analysis
Midsona AB Class B
―
Humble Group AB
―
Skane-moellan AB
―
Cheffelo AB
―
Premium Snacks Nordic AB
―